Monthly Investor Meetup
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
An exploration of how software and data-driven solutions are reshaping healthcare delivery, research, and operations. The session distinguishes digital health, health tech, and tech bio, while highlighting how integration, user...
Contact us to be added to the meeting invite.
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
Contact us to be added to the meeting invite.
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
Contact us to be added to the meeting invite.
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
Contact us to be added to the meeting invite.
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
Contact us to be added to the meeting invite.
A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.
Contact us to be added to the meeting invite.
Set the foundation for new and returning investors. Cover why life sciences investing matters, how it differs from traditional tech investing, what makes the Kansas City opportunity unique, and what...
Focus on how investors identify opportunities, prioritize pipeline, and conduct early diligence screening. This would include discussion around technical risk, regulatory pathways, IP, clinical/commercial milestones, founder credibility, and scientific validation....